In The News
- Home
- In The News
Clinical Announcement
We are pleased to announce that RevitalLife is participating in an Institutional Review Board (IRB) study evaluating the efficacy of stem cell and exosome therapies for orthopedic indications, with particular emphasis on shoulder and knee conditions.
Exosome Research Updates
- Exosome market shifts from quantity to proven efficacy - Personal Care Insights
- Exosomes Market Size, Industry Share, Forecast, 2034 - Fortune Business Insights
- The Next Era of Skincare Innovation and How Brands Can Respond: Biology, Delivery and Longevity - Mintel
- These are the Top 10 emerging technologies of 2026 - The World Economic Forum
- WEF Report: 10 Technologies Set To Reshape Industry, Infrastructure - Business Facilities
- Exosome Therapeutics Market Set to Surge - Key Insights You Must Know | Valuates Reports - openPR.com
- Exosome-based Therapeutics Market Size Report, 2026-2033 - Grand View Research
- Skin Boosters Market Size, Share, Growth, Analysis, Report, 2034 - Straits Research
- Biotech Beauty Boom Shifts Industry Focus to Science, IP, and Clinical Innovation - BeautyMatter
- Exosome Therapy Market Size and Industry Dynamics 2026-2035 - Standardization Challenges Loom Over Booming $58 Billion Exosome Therapy Industry - Yahoo Finance
Stem Cell Research Updates
- Optimized chemogenetic ablation and regeneration of enteric nervous system neurons in zebrafish
- Topical vascular organoid therapy promotes microvascular regeneration and functional recovery in porcine ischemic cardiomyopathy
- Allogeneic islet products for type 1 diabetes: Navigating nonclinical and manufacturing regulatory expectations
- Integration of the naive pluripotency gene network with the response to GSK3 inhibition by Tcf7l1-driven enhancer decommissioning
- BDNF regulates pituitary stem cell engagement toward precursor state
- Atg5 deficiency alters myofibroblast accumulation and alveolar regeneration in lung fibrosis
- Neural stem cells as potential mediators of prenatal dietary stress through epigenetic mechanisms
- A highly efficient method to differentiate CGRP-expressing peptidergic nociceptors from human induced pluripotent stem cells
- Integrative analysis of drug-gene signatures in human pluripotent stem cells reveals prazosin as a novel SQSTM1 regulator for ALS therapeutics
- Rewiring ALS by modulating the autophagy receptor SQSTM1